TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 19:35 | 2/8/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | S.d | -59 | 14.93 | 0 | -4 | -2 | 215 | D | ||||||||||||||
12/18/23 17:34 | 12/15/23 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | S | -155 | 15.50 | 0 | -10 | -6 | 165 | D | ||||||||||||||
12/5/23 16:52 | 12/1/23 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | S.m | -287 | 14.35 | 0 | -20 | -10 | 175 | D | ||||||||||||||
11/20/23 16:53 | 11/17/23 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | S | -140 | 14.00 | 0 | -10 | -5 | 195 | D | ||||||||||||||
11/13/23 17:25 | 11/8/23 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | S | -65 | 13.00 | 0 | -5 | -2 | 205 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |